New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 4, 2014
10:02 EDTBTU, SWN, PBPB, JPM, GME, EGO, APAM, BGS, NOW, PSO, HUN, FINL, DYN, ANN, MYL, UPL, SNI, MYGN, GCO, EMES, BLK, APCOn The Fly: Analyst Upgrade Summary
Anadarko (APC) upgraded to Overweight from Underweight at JPMorgan... Ann Inc. (ANN) upgraded to Outperform from Neutral at Macquarie... Artisan Partners (APAM) upgraded to Outperform from Market Perform at Keefe Bruyette... BlackRock (BLK) upgraded to Outperform from Market Perform at Keefe Bruyette... Dynegy (DYN) upgraded to Neutral from Sell at UBS... Eldorado Gold (EGO) upgraded to Buy from Hold at Canaccord... Emerge Energy Services (EMES) upgraded to Outperform from Neutral at RW Baird... Finish Line (FINL) upgraded to Overweight from Equal Weight at Morgan Stanley... GameStop (GME) upgraded to Buy from Neutral at BofA/Merrill... Genesco (GCO) upgraded to Buy from Neutral at Sterne Agee... Huntsman (HUN) upgraded to Buy from Neutral at UBS... JPMorgan (JPM) upgraded to Outperform from Neutral at Macquarie... Myriad Genetics (MYGN) upgraded to Buy from Neutral at Mizuho... Pearson (PSO) upgraded to Buy from Hold at Jefferies... Potbelly (PBPB) upgraded to Outperform from Market Perform at William Blair... Scripps Networks (SNI) upgraded to Buy from Hold at Wunderlich... ServiceNow (NOW) upgraded to Overweight from Equal Weight at Evercore... Southwestern Energy (SWN) upgraded to Buy from Neutral at ISI Group... Ultra Petroleum (UPL) upgraded to Neutral from Cautious at ISI Group... B&G Foods (BGS) upgraded to Overweight at Stephens... Mylan (MYL) upgraded to Buy from Neutral at Citigroup... Peabody (BTU) upgraded to Outperform from Market Perform at Cowen.
News For APC;ANN;APAM;BLK;DYN;EGO;EMES;FINL;GME;GCO;HUN;JPM;MYGN;PSO;PBPB;SNI;NOW;SWN;UPL;BGS;BTU;MYL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
June 18, 2015
07:46 EDTMYLMylan initiated with a Buy at BTIG
Subscribe for More Information
06:46 EDTFINLFinish Line risk/reward into Q1 results, says Piper Jaffray
Subscribe for More Information
06:09 EDTMYLTeva raises stake in Mylan to 4.3%, Globes reports
Subscribe for More Information
June 17, 2015
14:55 EDTJPMJPMorgan announces unexpected death of Vice Chairman Jimmy Lee
Subscribe for More Information
11:16 EDTJPMOCC restricts some banks from certain mortgage related business activity
Subscribe for More Information
06:48 EDTJPMMore big banks waiving overdraft fees, WSJ reports
Subscribe for More Information
June 16, 2015
19:47 EDTGMEXbox chief says digital game sales 'really strong,' WSJ reports
Subscribe for More Information
18:33 EDTJPMJPMorgan shareholder suit over 'London Whale' dismissed, Reuters reports
Subscribe for More Information
14:12 EDTMYLAbbott backing marginally ups chances of Mylan-Perrigo deal, says BMO Capital
Subscribe for More Information
11:06 EDTMYLTeva says 'fully committed' to bid for Mylan, Bloomberg reports
After Abbott (ABT) announced earlier that it intends to vote its 14.5% stake in Mylan (MYL) in favor of Mylan's proposed acquisition of Perrigo (PRGO), a Teva (TEVA) spokesperson told Bloomberg in an email that the company remains "fully committed" to is offer to acquire Mylan, which Teva said is better than Mylan's suggested deal for Perrigo.
10:29 EDTMYLGeneric drugs may be targets of congressional price probe, Bloomberg says
In addition to branded drugs that were cited for "staggering" price increases in a congressional probe on drug prices being led by U.S. Senator Bernie Saunders, generic drug makers may also be targeted, stated Bloomberg Intelligence. Data show some generics, including clomipramine hydrochloride and tetracycline, have seen "aggressive" quarterly price increases, the report noted. Generic drug makers that could be caught up in the probe include Mallinckrodt (MNK), Teva (TEVA), Novartis' (NVS) Sandoz unit, Mylan (MYL), Taro Pharmaceutical (TARO) and Teva (TEVA). Mallinckrodt shares are down about 4% in early trading.
10:01 EDTEGOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:01 EDTSWNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:21 EDTMYLMylan issues statement regarding Abbott's support for Perrigo transaction
Subscribe for More Information
09:10 EDTMYLAbbott confirms support for Mylan's proposed acquisition of Perrigo
Abbott (BT) confirmed its continued support for Mylan (MYL) N.V's growth strategy by stating its intent to vote its 14.5% stake in Mylan in favor of Mylan's proposed acquisition of Perrigo (PRGO). "We chose Mylan to acquire our developed markets branded generics pharmaceuticals because its scale and breadth across critical distribution channels, broad and diverse portfolio, and commitment to patients and product quality strongly positions it for success in the years to come," said Abbott. "As both Mylan's largest shareholder and its partner through our continued manufacturing relationships, Abbott has considered the entire situation and we believe Mylan's standalone strategy and acquisition of Perrigo will further enhance its platform, is strategically compelling, value enhancing for shareholders, and offers a clear path to completion. In light of these factors, we will be voting in favor of the Perrigo transaction."
08:54 EDTMYLPulmatrix enter into development agreement with Mylan for PUR0200
Pulmatrix (PULM) announced that it has entered into an ex-U.S. development agreement with Mylan (MYL). The agreement is for PUR0200, a clinical stage bronchodilator therapy being studied for chronic obstructive pulmonary disease, or COPD, and the first small molecule formulation from the company's novel iSPERSE inhaled dry powder technology. PUR0200 is under development as a once-daily therapy in a capsule-based dry powder inhaler, or DP. Under the terms of the agreement, Pulmatrix will lead the development work and pharmacokinetic clinical study with collaborative support from Mylan. Mylan has retained an option for PUR0200 ex-U.S. based on successful completion of the clinical study. Financial terms of the agreement are confidential.
08:53 EDTSWNSouthwestern Energy upgraded to Accumulate from Hold at Tudor Pickering
Subscribe for More Information
07:11 EDTJPMSurprise AIG ruling may make future bailouts unlikely, even if needed, NYT says
Subscribe for More Information
06:33 EDTEGOEldorado Gold initiated with a Market Perform at BMO Capital
06:19 EDTJPMJPMorgan, HSBC could move parts of businesses to Luxembourg, U.K. Times reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use